A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

August 31, 2017

Primary Completion Date

July 28, 2020

Study Completion Date

April 28, 2021

Conditions

Multiple Myeloma

Interventions

DRUG

Venetoclax

Tablet

DRUG

ABBV-838

Intravenous infusion

DRUG

Dexamethasone

Tablet or intravenous infusion

Trial Locations (3)

St Vincent´s Hospital /ID# 153022, Darlinghurst

St. Vincents Hospital Melbourne /ID# 157925, Fitzroy

The Alfred Hospital /ID# 150202, Prahran